Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    STK11
Show Display Options
Rank Status Study
1 Recruiting Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations
Conditions: Solid Malignancy;   Solid Tumor
Intervention: Drug: Everolimus
2 Not yet recruiting Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: Standard therapy or clinical trial;   Drug: Matched targeted therapy;   Drug: Trametinib and / or supportive care
3 Recruiting French Digestive Polyposis Cohorte Family Adenomatous Polyposis With APC and MYH Gene Mutations , Cowden's Disease With PTEN Gene Mutation, Peutz Jeghers Disease With STK 11 Gene Mutation ,juvénil Polyposis With SMAD 4 Gene Mutation , Serrated and Hyperplastic Polyposis
Condition: Quality of Life
Interventions: Other: Procedure surgery behavioral and genetic diagnosis;   Procedure: quality of life after different type of surgery
4 Completed Pharmacogenetics of Metformin Action in PCOS
Condition: Polycystic Ovary Syndrome
Intervention: Drug: Metformin 500 mg tablet
5 Recruiting Metformin in Non Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Interventions: Drug: Metformin;   Other: Placebo;   Radiation: Stereotactic body Radiotherapy (SBRT)
6 Recruiting Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
Conditions: Breast Cancer;   Ovarian Cancer;   Colorectal Cancer;   Pediatric Cancers;   Multiple Primary Malignant Tumours
Intervention: Genetic: Genetic analysis
7 Recruiting The Cancer of the Pancreas Screening-5 CAPS5)Study
Conditions: Pancreas Cancer;   Peutz-Jeghers Syndrome;   Gene Mutation;   Germline Mutation Carrier;   Lynch Syndrome
Intervention: Drug: Human synthetic secretin

Indicates status has not been verified in more than two years